Public COA audit
CJC-1295/Ipamorelin
Audited September 5, 2026
Several fields check out, but we found issues worth reviewing before you rely on this document.
- Legitimacy
- 92
- Confidence
- 95%
- Panels
- 1/7
Scored high because the document is mostly consistent but carries soft concerns, limited panel coverage (1/7), and 1 soft concern. To improve: include identity, purity, and endotoxin at minimum.
Document details
Fields extracted from the certificate — not order or payment data.
- Batch / lot
- 7-3-45959
- Sample date
- 2025-11-19
- Issue date
- 2025-11-19
Original certificate
Embedded copy of the stored COA PDF or image. Download it for your records — PeptIQ’s audit is separate from the lab document itself.
7-panel checklist
Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.
1 of 7 present · 1 passed · 0 failed · 0 reported · 6 missing
Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.
Identity
Not on this certificate file · core
Compound identity confirmed (e.g. HPLC, mass spec).
No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”
Purity
Not on this certificate file · core
Reported purity percentage for the analyte.
No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”
Heavy metals
Not on this certificate file
Lead, arsenic, cadmium, mercury, or similar limits.
No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”
Microbial
Not on this certificate file
Bioburden / microbial limits testing.
No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”
Endotoxin
Tested · passed · core
LAL or chromogenic endotoxin assay.
< 0.050 EU/mL
Sterility
Not on this certificate file
Sterility testing where applicable.
No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”
Residual solvent / water
Not on this certificate file
Residual solvents or water content limits.
No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”
How to read this
Had data · good
Panel present with a pass (or clear acceptance).
Had data · bad
Panel present with a fail — a concrete quality signal.
Had data · unclear
Value reported without an explicit pass/fail mark.
Missing on this file
Not on this certificate file. Lowers file thoroughness; a sibling endotoxin/purity report for the same lot may still exist. PeptIQ’s score still factors coverage.
Findings
Evidence-linked observations from this audit.
Endotoxin testing performed
Chromogenic LAL assay (Endosafe-PTS) performed with result < 0.050 EU/mL, passing specification of < 0.25 EU/mL. Detection range 0.05-5.0 EU/mL, spike recovery 82% (Pass).
Endotoxin-only report
This is a specialized endotoxin testing report from BioRegen. It does not include purity, identity, heavy metals, microbial, sterility, or residual solvent panels. The client (Biolongevity Labs) may have separate reports for those tests.
Verification features present
Report includes Report ID (BL-ENDO-251911-169), Validation Key (BIOLABS2010), QR code for verification, and contact information ([email protected], www.bioregen.com).
Test date valid
Test date 2025-11-19 is within acceptable range (before today 2026-09-05).
Sample information complete
Lot number 7-3-45959, sample concentration 5/5 mg, tested by analyst MARIN using Endosafe nexgen-PTS (SN: 25201216).
Professional presentation
Report follows standard laboratory format with clear tables, analyst signature, and interpretation section explaining the chromogenic LAL assay methodology and acceptance criteria.
PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.